# A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine

> **NCT05047770** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 2013 (actual)

## Conditions studied

- Herpes Zoster

## Interventions

- **BIOLOGICAL:** HZ/su
- **COMBINATION_PRODUCT:** Flu D-QIV
- **BIOLOGICAL:** mRNA-1273

## Key facts

- **NCT ID:** NCT05047770
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-07
- **Primary completion:** 2022-08-29
- **Final completion:** 2022-08-31
- **Target enrollment:** 2013 (ACTUAL)
- **Last updated:** 2023-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05047770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05047770, "A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05047770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*